Published in Cancer Res on April 01, 2008
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
The role of aspirin in women's health. Int J Womens Health (2011) 1.39
Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev (2009) 1.23
Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2010) 1.13
Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol (2012) 1.13
Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect. Carcinogenesis (2010) 1.12
Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) (2011) 1.08
Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol (2009) 1.01
Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006. Int J Cancer (2011) 0.96
Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila) (2009) 0.95
Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes Control (2012) 0.91
Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control (2012) 0.88
Perineal use of talcum powder and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 0.86
Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One (2014) 0.82
Comparison of clinical efficacy of intravenous acetaminophen with intravenous morphine in acute renal colic: a randomized, double-blind, controlled trial. Emerg Med Int (2014) 0.78
Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer. Horm Cancer (2012) 0.77
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst (2017) 0.76
Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract. J Immunol Res (2016) 0.75
Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies. Cancer Causes Control (2016) 0.75
Use of acetaminophen and risk of endometrial cancer: evidence from observational studies. Oncotarget (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77
Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology (2001) 3.51
A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst (2004) 3.49
Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Inflammatory cells and cancer: think different! J Exp Med (2001) 2.42
Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology (1996) 2.30
Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res (1988) 2.28
Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res (2003) 1.98
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.35
Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer (2005) 1.22
Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer (2004) 1.20
Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.17
Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst (2004) 1.13
Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol (2000) 1.09
Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer (2001) 1.09
Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet (1999) 1.07
Aromatase and cyclooxygenases: enzymes in breast cancer. J Steroid Biochem Mol Biol (2003) 1.07
COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids (2005) 1.06
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci (2004) 1.03
Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer (2002) 0.98
Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer (1992) 0.97
Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol (2005) 0.92
Hormone replacement therapy and endometrial cancer in Ontario, Canada. J Clin Epidemiol (2000) 0.92
A population-based case-control study of endometrial cancer in Shanghai, China. Int J Cancer (1991) 0.88
Aspirin effects on endometrial cancer cell growth. Obstet Gynecol (2001) 0.87
A case-control study of cancer of endometrium in Athens. Int J Cancer (1989) 0.87
Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol (2003) 0.85
Basal hormone levels in women who use acetaminophen for menstrual pain. Fertil Steril (1998) 0.83
Implantation, menstruation and inflammation. Biol Rev Camb Philos Soc (1986) 0.83
Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression. Int J Gynecol Cancer (2007) 0.82
Inflammatory mediators and endometrial function--focus on the perivascular cell. J Reprod Immunol (2002) 0.80
The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma. Ann Med (2002) 0.79
Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception (2004) 0.78
The role of prostaglandins and allied substances in uterine haemostasis. Contraception (1987) 0.77
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med (2011) 3.88
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst (2008) 3.54
A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol (2008) 3.17
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol (2006) 3.09
Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol (2013) 3.08
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One (2008) 2.92
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Melatonin secretion and the incidence of type 2 diabetes. JAMA (2013) 2.65
Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut (2012) 2.65
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62
Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med (2006) 2.60
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56
Long-term aspirin use and mortality in women. Arch Intern Med (2007) 2.54
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ (2012) 2.45
Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum (2007) 2.44
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer (2005) 2.35
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst (2007) 2.34
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Night shift work and the risk of endometrial cancer. Cancer Res (2007) 2.28
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26
Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr (2012) 2.25
A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 2.23
Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension (2002) 2.16
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst (2002) 2.16
Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn (2010) 2.15
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2005) 2.15
Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med (2010) 2.15
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11
Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03
Sleep duration and risk for hypertension in women: results from the nurses' health study. Am J Hypertens (2013) 2.03
Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care (2003) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2007) 2.01
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer (2007) 2.01
Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol (2009) 1.99
Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr (2005) 1.97
Cigarette smoking and the incidence of breast cancer. Arch Intern Med (2011) 1.97
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95